Urination disorders. Do we know all about them?
- Autores: Gadzhieva Z.K1, Kazilov Y.B1,2, Alyaev Y.G1, Aboyan I.A3, Kazilov B.R4
-
Afiliações:
- First MSMU n.a. I.M. Sechenov
- Republican Urological Center, Makhachkala
- MBNCI CDC «Health»
- Republican Urological Center
- Edição: Nº 1 (2014)
- Páginas: 20-27
- Seção: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/280097
- ID: 280097
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
The article presents the results of the pilot questionnaire survey of doctors of various specialties, living in some cities in the Southern Federal District, in the diagnosis and treatment of various urination disorders. The survey involved 101 urologists, 33 obstetricians, 37 internists, 35 surgeons, 9 neurologists and 1 infectiologist. Inadequate training of doctors of various specialties regarding the diagnosis and treatment of various disorders of urination of inflammatory and non-inflammatory nature should be noted. Misunderstanding of differential diagnosis of various forms of urinary incontinence and tactics of management of each of them come under notice. Most urologists (95.46%), obstetricians (92.3%), physicians (100%), neurologists (66.6%), and surgeons (88.58%) did not have a thorough knowledge about the symptoms of overactive bladder (OB). Only 63.37 % of the entire group of respondents, and 81% of urologists using conservative therapies, has prescribed M-anticholinergics for the treatment of OB. In the treatment of urgent forms of urinary incontinence, only 64.5% of urologists use M-anticholinergics. Excessive use of M-anticholinergics for the treatment of stress urinary incontinence still persists - 38 % of urologists. а- blockers are the main group of drugs (96.6%) used in medical treatment of LUTS in benign prostatic hyperplasia. However, there is reduced (14.8%) understanding of the need to designate combination therapy with M-cholinergic antagonists when indicated. The issues of therapy of patients with lower urinary tract infections, namely the choice of antibiotics without considering antibiotic sensitivity and antibiotic resistance and knowledge of Russian and national guidelines and recommendations of the European Association of Urology are of particular concern. Curiously enough, there is underestimation of this issue by urologists (23%) compared to obstetricians (45%) and physicians (40.7%). These findings can determine the need for education programs for professionals in different areas of medicine, because patients with urination disorders occur in practice of doctors of various related specialties.
Texto integral
Sobre autores
Z. Gadzhieva
First MSMU n.a. I.M. Sechenov
Email: zaida-gadzhieva@rambler.ru
Yu. Kazilov
First MSMU n.a. I.M. Sechenov; Republican Urological Center, Makhachkala
Yu. Alyaev
First MSMU n.a. I.M. Sechenov
I. Aboyan
MBNCI CDC «Health»Rostov-on-Don
B. Kazilov
Republican Urological CenterMakhachkala
Bibliografia
- Bachmann G. Urogenital ageing and old problem newly recognized. Maturitas. 1995; 22(Suppl.): 1-5.
- Abrams P., Wein A.J. Introduction: Overactive bladder and its treatmens. Urology. 2000; 55(Suppl. 5A): 1-2.
- Abrams P., Wein A. Overactive bladder (tetter reply). Urology. 1998; 51: 1062.
- Лоран О.Б., Годунов Б.Н., Корсунская И.Л. Эндовезикальный ионофорез в лечении хронического цистита у женщин. Клиническая фармакология и терапия. 1996; 5(2): 17-20.
- Perrotta C., Aznar M., Mejia R. et al. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women Cochrane Database of Systematic Reviews 2008, Issue 2.
- http://www.cistit.net.
- EAU pocket Guidelines on urological infections. 2013: 202-203.
- EAU pocket Guidelines on management of male lower urinary tract symptoms (LUTS), incl. bening prostatic obstruction (BPO). 2013: 121-122.
- Рафальский В.В., Белокрысенко С.С., Малев И.В. и др. Чувствительность возбудителей инфекций мочевыводящих путей, выделенных в Российской федерации к пероральному цефалоспорину III поколения Супракс Солютаб (цефиксим). Лечащий врач. 2008; 8: 27-29.
- Gyssens I.C. All EU hands to the EU pumps: the Science Academies of Europe (EASAC) recommend strong support of research to tackle antibacterial resistance. Clin. Microbiol. Infect. 2008; 14: 889-891.
- Nicolle L. Empirical treatment of acute cystitis in women. Int. J Antimicrob. Agents. 2003; 22(1): 1-6.
- Skerk V., Krehen I., Schutnwald S. Antimicrobal therapy of urinary tract infections. Lijec. Vjesn. 2001; 123(1-2): 16-25.
- Рафальский В.В., Страчунский Л.С., Кречикова О.И. и др. Оптимизация антимикробной терапии амбулаторных инфекций мочевыводящих путей по данным многоцентровых микробиологических исследований UTIAP-1, UTIAP-11. Урология. 2004; 4: 13-17.
- Uncomplicated UTIS in adults. E.A.U. Guidlines on urinary tract and male genital tract infections. P. 9-14.
- Рафальский В.В. и соавт. Лечащий врач. 2008; (8): 1-3.
- Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов. Российские национальные рекомендации. М., 2012.
- Grabe M., et al. European Association of Urology Guidelines on Urological Infections 2012: 21.